NBIX
Neurocrine Biosciences, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham +7.0% · posisi baru bersih 0.0% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q1 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 5 | -1 | 774.42K | $108.76M | n/a | −1 |
| Q2 2026 | 154 | 0 | 76.05M | $12.81B | +5 | −4 |
| Q1 2026 | 156 | 0 | 77.10M | $10.14B | +6 | −7 |
| Q4 2025 | 155 | 0 | 77.25M | $10.95B | +1 | n/a |
| Q3 2025 | 22 | 0 | 59.57M | $8.36B | +1 | −2 |
| Q2 2025 | 20 | -1 | 49.44M | $6.21B | +2 | −3 |
| Q1 2025 | 18 | 0 | 22.97M | $2.54B | +1 | −1 |
| Q4 2024 | 18 | 0 | 21.48M | $2.93B | +1 | −1 |
| Q3 2024 | 17 | 0 | 13.43M | $1.55B | n/a | n/a |
| Q2 2024 | 17 | n/a | 11.91M | $1.64B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 5.53M | +83.5% | $612.13M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (pasif) | 4.86M | -0.6% | $537.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 2.50M | +0.5% | $276.80M | 0.4% | ▲ Add | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.10M | +44.0% | $232.04M | 0.0% | ▲ Add | 4 | SEC ↗ ×6 |
| 5 | Geode Capital Management ✦ (pasif) | 1.97M | +5.0% | $217.41M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 6 | T. Rowe Price ✦ | 1.54M | +3.3% | $170.28M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 7 | AQR Capital Management ✦ | 1.07M | -43.4% | $118.85M | 0.1% | ▼ Trim | 4 | SEC ↗ ×7 |
| 8 | Norges Bank ✦ (pasif) | 999.82K | +207.4% | $110.58M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 889.03K | -65.0% | $98.33M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 10 | Millennium Management ✦ | 576.59K | +37.7% | $63.77M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 11 | PRIMECAP Management ✦ | 382.44K | -2.9% | $42.30M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Soros Fund Management ✦ | 239.82K | +19.9% | $26.52M | 0.7% | ▲ Add | 4 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 95.26K | +3.4% | $10.54M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 87.24K | -73.8% | $9.65M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 66.60K | Baru | $7.37M | 0.0% | New | 1 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 31.02K | +442.9% | $3.43M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 14.59K | -49.2% | $1.61M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 10.20K | -61.9% | $1.13M | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Arrowstreet Capital | $7.37M | 0.0% |
Telah keluar
| Marshall Wace | $331,013 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 690 pemegang, 94.09M saham, $12.08B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 826 lbr · $130,051
Officer · 2.31K lbr · $363,285
Officer · 2.15K lbr · $333,030
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi